In severe COVID-19 cases, it has been reported that CD8 + T cells exhibit a high proportion of CD57 + terminal effector cells, together with significant decrease of naïve cell population leaving unresolved inflammation 6 months after infection80. Here, B3GAT1 is linked to COVID-19.